C15ORF33 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.636010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.952400E-01
Normal-vs-Stage2
2.184200E-02
Normal-vs-Stage3
1.243570E-01
Normal-vs-Stage4
2.311400E-01
Stage1-vs-Stage2
1.714610E-01
Stage1-vs-Stage3
1.727790E-01
Stage1-vs-Stage4
2.783800E-01
Stage2-vs-Stage3
9.104400E-01
Stage2-vs-Stage4
8.530800E-01
Stage3-vs-Stage4
8.184200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.834590E-01
Normal-vs-AfricanAmerican
1.562370E-01
Normal-vs-Asian
9.093700E-02
Caucasian-vs-AfricanAmerican
9.126200E-01
Caucasian-vs-Asian
3.021800E-01
AfricanAmerican-vs-Asian
3.790200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.179180E-01
Normal-vs-Female
2.449000E-01
Male-vs-Female
3.065800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.098200E-01
Normal-vs-Age(41-60Yrs)
2.192800E-01
Normal-vs-Age(61-80Yrs)
1.175450E-01
Normal-vs-Age(81-100Yrs)
3.025800E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.747000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.422200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.138400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.363600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.416400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.532800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.624500E-02
Normal-vs-Daily Drinker
6.297500E-03
Normal-vs-Weekly Drinker
7.557700E-03
Normal-vs-Occasional Drinker
4.936000E-01
Normal-vs-Social Drinker
5.805000E-01
Non Drinker-vs-Daily Drinker
1.793850E-01
Non Drinker-vs-Weekly Drinker
6.448000E-02
Non Drinker-vs-Occasional Drinker
5.273400E-01
Non Drinker-vs-Social Drinker
2.360200E-01
Daily Drinker-vs-Weekly Drinker
3.725400E-01
Daily Drinker-vs-Occasional Drinker
1.852350E-01
Daily Drinker-vs-Social Drinker
5.975900E-02
Weekly Drinker-vs-Occasional Drinker
8.820200E-02
Weekly Drinker-vs-Social Drinker
2.515600E-02
Occasional Drinker-vs-Social Drinker
6.971400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.77075999999721E-05
Normal-vs-Grade 2
4.825700E-02
Normal-vs-Grade 3
3.059900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.080600E-01
Grade 1-vs-Grade 3
7.569900E-02
Grade 1-vs-Grade 4
1.77075999999721E-05
Grade 2-vs-Grade 3
6.151000E-01
Grade 2-vs-Grade 4
4.825700E-02
Grade 3-vs-Grade 4
3.059900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.158240E-01
Normal-vs-NonDiabetic
1.866020E-01
Diabetic-vs-NonDiabetic
6.553600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.269950E-02
Normal-vs-NoPancreatitis
2.154800E-01
Pancreatitis-vs-NoPancreatitis
5.003800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.891400E-01
Normal-vs-N1
1.902220E-02
N0-vs-N1
1.299350E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.502600E-01
Normal-vs-TP53-NonMutant
8.146600E-01
TP53-Mutant-vs-TP53-NonMutant
4.158400E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
